STOCK TITAN

[SCHEDULE 13G/A] TALPHERA, INC. Amended Passive Investment Disclosure

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Talphera, Inc. received an updated ownership filing showing that investor Laurence W. Lytton and the Lytton-Kambara Foundation together report beneficial ownership of 2,730,718 shares of Talphera common stock, or 5.9% of the company.

Both reporting persons have shared voting and shared dispositive power over these shares, with no sole power to vote or dispose. The percentage is based on 46,609,618 shares outstanding as of November 5, 2025, as cited from Talphera’s Form 10-Q. They certify the holdings were not acquired to change or influence control of Talphera.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 46,609,618 shares of Common Stock outstanding on November 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarterly period ended September 30, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 46,609,618 shares of Common Stock outstanding on November 5, 2025, as reported in the Form 10-Q filed by the Issuer for the quarterly period ended September 30, 2025.


SCHEDULE 13G



LYTTON LAURENCE W
Signature:/s/ Laurence W. Lytton
Name/Title:Reporting Person
Date:02/17/2026
LYTTON-KAMBARA FOUNDATION
Signature:/s/ Laurence W. Lytton
Name/Title:President
Date:02/17/2026
Exhibit Information

EXHIBIT 99.1 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G

Talphera Inc

NASDAQ:TLPH

TLPH Rankings

TLPH Latest News

TLPH Latest SEC Filings

TLPH Stock Data

37.75M
29.97M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SAN MATEO